Zolbetuximab + CAPOX in 1L Claudin-18.2+(CLDN18.2+)/HER2-locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW Meeting Abstract


Authors: Lordick, F.; Xu, R. H.; Shitara, K.; Ajani, J. A.; Bang, Y. J.; Enzinger, P.; Ilson, D.; Van Cutsem, E.; Plazas, J. G.; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Hoo, H. F. S.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Arozullah, A.; Shah, M. A.
Abstract Title: Zolbetuximab + CAPOX in 1L Claudin-18.2+(CLDN18.2+)/HER2-locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023)
Journal Title: Oncology Research and Treatment
Volume: 46
Issue: Suppl. 5
Meeting Dates: 2023 Oct 13-16
Meeting Location: Hamburg, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2023-10-01
Start Page: 116
End Page: 117
Language: English
ACCESSION: WOS:001091456900245
PROVIDER: wos
PUBMED: 37788643
DOI: 10.1159/000533576
Notes: Meeting Abstract: V842 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David H Ilson
    434 Ilson